Inducible over‐expression of wild type α‐synuclein in human neuronal cells leads to caspase‐dependent non‐apoptotic death
暂无分享,去创建一个
Kostas Vekrellis | Evangelia Emmanouilidou | Maria Xilouri | Leonidas Stefanis | M. Xilouri | L. Stefanis | Evangelia Emmanouilidou | K. Vekrellis
[1] Olaf Riess,et al. AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease , 1998, Nature Genetics.
[2] B. Winblad,et al. Flow cytometry as a method for studying effects of stressors on primary rat neurons , 2005, Journal of neuroscience research.
[3] M. Xilouri,et al. A novel cell death pathway that is partially caspase dependent, but morphologically non‐apoptotic, elicited by proteasomal inhibition of rat sympathetic neurons , 2008, Journal of neurochemistry.
[4] L. Greene,et al. Neuroprotective Actions of Dipyridamole on Cultured CNS Neurons , 1998, The Journal of Neuroscience.
[5] Kostas Vekrellis,et al. Neurobiology of α-synuclein , 2004, Molecular Neurobiology.
[6] Janel O. Johnson,et al. α-Synuclein Locus Triplication Causes Parkinson's Disease , 2003, Science.
[7] P. Fraser,et al. Inositol Stereoisomers Stabilize an Oligomeric Aggregate of Alzheimer Amyloid β Peptide and Inhibit Aβ-induced Toxicity* , 2000, The Journal of Biological Chemistry.
[8] D. Bredesen. Programmed cell death mechanisms in neurological disease. , 2008, Current molecular medicine.
[9] H. Reichmann,et al. Neuronal differentiation and long-term culture of the human neuroblastoma line SH-SY5Y. , 2007, Journal of neural transmission. Supplementum.
[10] Aldo Quattrone,et al. Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease. , 2006, JAMA.
[11] Kostas Vekrellis,et al. Wild Type α-Synuclein Is Degraded by Chaperone-mediated Autophagy and Macroautophagy in Neuronal Cells* , 2008, Journal of Biological Chemistry.
[12] Robert L. Nussbaum,et al. Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease , 1997 .
[13] D. Price,et al. Stabilization of α-Synuclein Protein with Aging and Familial Parkinson's Disease-Linked A53T Mutation , 2004, The Journal of Neuroscience.
[14] R. Korneluk,et al. The inhibitors of apoptosis: there is more to life than Bcl2 , 2003, Oncogene.
[15] J. Kordower,et al. Age-associated increases of α-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion: Is this the target for Parkinson's disease? , 2007, Neurobiology of Disease.
[16] K. Prasad,et al. Overexpression of human α-synuclein causes dopamine neuron death in rat primary culture and immortalized mesencephalon-derived cells , 2000, Brain Research.
[17] D. Selkoe,et al. Effects of secreted oligomers of amyloid β‐protein on hippocampal synaptic plasticity: a potent role for trimers , 2006, The Journal of physiology.
[18] David S. Park,et al. Caspase-Dependent and -Independent Death of Camptothecin-Treated Embryonic Cortical Neurons , 1999, The Journal of Neuroscience.
[19] P. Lockhart,et al. Parkin Protects against the Toxicity Associated with Mutant α-Synuclein Proteasome Dysfunction Selectively Affects Catecholaminergic Neurons , 2002, Neuron.
[20] L. Greene,et al. Multiple agents rescue PC12 cells from serum-free cell death by translation- and transcription-independent mechanisms , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[21] J. Jankovic,et al. Nurr1 in Parkinson's disease and related disorders , 2006, The Journal of comparative neurology.
[22] R E Burke,et al. Apoptosis in neurodegenerative disorders. , 1997, Current opinion in neurology.
[23] J. Hoenicka,et al. The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia , 2004, Annals of neurology.
[24] Alexei Degterev,et al. A decade of caspases , 2003, Oncogene.
[25] W. Dauer,et al. Parkinson's Disease Mechanisms and Models , 2003, Neuron.
[26] D. Villa,et al. Retinoic acid‐induced neuritogenesis of human neuroblastoma SH‐SY5Y cells is ERK independent and PKC dependent , 2004, Journal of neuroscience research.
[27] S. Cory,et al. Life-or-death decisions by the Bcl-2 protein family. , 2001, Trends in biochemical sciences.
[28] L. Greene,et al. Expression of A53T Mutant But Not Wild-Type α-Synuclein in PC12 Cells Induces Alterations of the Ubiquitin-Dependent Degradation System, Loss of Dopamine Release, and Autophagic Cell Death , 2001, The Journal of Neuroscience.
[29] Hai Lin,et al. Amyloid ion channels: a common structural link for protein-misfolding disease. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[30] D. Price,et al. Parkinson's Disease α-Synuclein Transgenic Mice Develop Neuronal Mitochondrial Degeneration and Cell Death , 2006, The Journal of Neuroscience.
[31] D. Selkoe,et al. Orally available compound prevents deficits in memory caused by the Alzheimer amyloid‐β oligomers , 2006, Annals of neurology.
[32] Yigong Shi,et al. Apoptosome: a platform for the activation of initiator caspases , 2007, Cell Death and Differentiation.
[33] Kostas Vekrellis,et al. Cell-produced α-synuclein oligomers are targeted to, and impair, the 26S proteasome , 2010, Neurobiology of Aging.
[34] B. Winblad,et al. Differential role of presenilin‐1 and ‐2 on mitochondrial membrane potential and oxygen consumption in mouse embryonic fibroblasts , 2006, Journal of neuroscience research.
[35] S. Cory,et al. Apoptosomes: engines for caspase activation. , 2002, Current opinion in cell biology.
[36] Philippe Amouyel,et al. α-synuclein locus duplication as a cause of familial Parkinson's disease , 2004, The Lancet.
[37] C. Ross,et al. Endoplasmic reticulum stress and mitochondrial cell death pathways mediate A53T mutant alpha-synuclein-induced toxicity. , 2005, Human molecular genetics.
[38] L. Greene,et al. Inhibitors of Trypsin‐Like Serine Proteases Inhibit Processing of the Caspase Nedd‐2 and Protect PC12 Cells and Sympathetic Neurons from Death Evoked by Withdrawal of Trophic Support , 1997, Journal of neurochemistry.
[39] L. Stefanis. Caspase-Dependent and -Independent Neuronal Death: Two Distinct Pathways to Neuronal Injury , 2005, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.
[40] P. Lansbury,et al. Vesicle permeabilization by protofibrillar alpha-synuclein: implications for the pathogenesis and treatment of Parkinson's disease. , 2001, Biochemistry.
[41] Chung-Shi Yang,et al. Simultaneous determination of myo‐inositol and scyllo‐inositol by MEKC as a rapid monitoring tool for inositol levels , 2007, Electrophoresis.
[42] A Dürr,et al. Causal relation between α-synuclein locus duplication as a cause of familial Parkinson's disease , 2004, The Lancet.
[43] Norbert Schuff,et al. Scyllo‐inositol in normal aging human brain: 1H magnetic resonance spectroscopy study at 4 Tesla , 2005, NMR in biomedicine.
[44] J. Deshusses,et al. Assymetry of the myo-inositol transport system in Klebsiella aerogenes. Energy is necessary to create the assymetry of the transport system. , 1977, European journal of biochemistry.
[45] Seung-Jae Lee,et al. Controlling the mass action of α‐synuclein in Parkinson’s disease , 2008, Journal of neurochemistry.
[46] I. Trougakos,et al. Glucocorticoid receptor isoforms in human hepatocarcinoma HepG2 and SaOS-2 osteosarcoma cells: presence of glucocorticoid receptor alpha in mitochondria and of glucocorticoid receptor beta in nucleoli. , 2005, The international journal of biochemistry & cell biology.
[47] Changlian Zhu,et al. Involvement of apoptosis‐inducing factor in neuronal death after hypoxia‐ischemia in the neonatal rat brain , 2003, Journal of neurochemistry.
[48] S. Lindquist,et al. α-Synuclein Blocks ER-Golgi Traffic and Rab1 Rescues Neuron Loss in Parkinson's Models , 2006, Science.
[49] A Masini,et al. Functional heterogeneity of an isolated mitochondrial population revealed by cytofluorometric analysis at the single organelle level. , 1996, Experimental cell research.